2 weeks left to register: 2nd How to Diagnose and Treat Acute Leukaemia!

February 24, 2020

2^nd HOW TO DIAGNOSE AND TREAT
ACUTE LEUKAEMIA

March 13-15, 2020
Budapest, Hungary
Chairs: Hervé Dombret, Arnold Ganser, Jorge Sierra, Wendy Stock

ABOUT THE CONFERENCE:
The programme of this “2^nd How to Diagnose and Treat: Acute Leukaemia” meeting will address the integration of genomic analysis and cutting-edge techniques for routine diagnosis, gene mutation-based therapies and new standard treatment algorithms, allogeneic haematopoietic stem cell (HSCT) transplantation and innovative immunotherapies, as well as the diagnosis and management of rare acute leukaemia subtypes.

This meeting will be valuable for you if you are looking for:

A cutting-edge scientific programme – from basic science to clinical and therapeutic applications and perspectives
Multiple opportunities for scientific interaction with an international faculty of distinguished experts
An emphasis on critical discussion

The meeting will provide clinicians and biologists with state-of-the-art recommendations regarding patient care and insights into controversies and new therapeutic perspectives in the field.

Learning Objectives:

Learn about the modern sets of diagnosis tests needed to optimally manage patients with AML and ALL
Review and hierarchize the new treatment standards that available to AML and ALL patients for front-line and for salvage therapy
Understand the value and role of leukaemic stem cell targeting and measurable residual disease (MRD) levels to stratify acute leukaemia therapy
Gain insight into emerging mechanisms associated with clinical resistance and leukaemia escape
Understand the effects and place of new immunotherapies with respect to standard or new HSCT procedures

More information

With the support of*